DatasetName,DDB2_S(23) DDB2_S(24) DDB2_S(26),DDB2_S(1) DDB2_S(3) DDB2_T(274)
RM2024_Intensity D4-1___3,,
RB2022_4_PostEndurance,,
FSO2013_Ratio M/L normalized Rep3,,
SR2019_MCF7_Biol_repl_3,0.6219484097150292,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,
SR2019_LM2_Biol_repl_1,,
RCJD2014_15min_1,0.5403502963252532,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,
CK2022_7 16-1,0.5893297287134758,
NJH2025_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_C,0.7094010562975167,
RKK2015_TNF-α/basal,,
JJ2018_Ratio H/M normalized pP2,,
NJH2025_Sub12_MICT_Pre,,
NJH2025_Sub7_MICT_Post,,
DL2023_control-3,,
ZX2022_Control Replicate 2,0.6200628952650165,
HS2024_6_B_T3,,
JW2015_Intensity pre1,,
IMM2018_normalised rep. int. Empty-3,,
AMK2021_30R_p5,,
FSO2013_Ratio M/L normalized Rep1,,
SR2019_MDAMB231_Biol_repl_4,,
GF2025_P2_Sph,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,
NJH2025_Sub13_HIIT_Mid,,
CP2009_Ratio M/L,,
NJH2025_Sub7_HIIT_Post,,
KBE2022_Log2_Ex_44_T,0.6667998618758575,
DB2022_Intensity L2,,
TM2022_mock.4h.C,,
AST2020_anti-CD3.2,0.6200993165724394,
CW2012_10 µM Erl/control Experiment 1 Replicate B,,
HS2024_7_B_N1,,
FSO2013_Ratio M/L normalized Rep1___1,,
SAS2015_AZD/DMSO_Exp3,,
RM2024_Intensity D0-2___3,,
RM2024_Intensity D6-1,,
RB2022_8_RecoverySprint,,
RB2022_5_PreEndurance,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,0.5689237457129149,
EP2017_Untreated R#4 normalized log2 ratio,0.564077583742998,0.4740673034536651
WZ2023_Pu_010_30min,0.7756645467278833,
AS2011_Ratio H/L Proteins RNAi_2,,
RB2022_4_PreStrength,,
NJH2024_Sub4_MICT_Post,,
AH2018_LFQ_M_1_X,0.7394242812223467,
RB2022_8_RecoveryEndurance,,
KBE2022_Log2_Ex_14_U,0.6705181743960845,
FSO2013_Ratio M/L normalized Rep3___3,,
AH2018_TMTMS3_1_C,0.6923656377608717,
JJ2018_Ratio H/L normalized___1,,
ZQ2022_C2,0.5648615989678738,
RB2022_5_PreSprint,,
PG2020_Intensity 8h_C,0.5100985507263519,
AH2018_SILAC_MR_2_N,0.7109030998365031,
MV2014_Ratio M/L normalized A1___2 (2 min),,
TM2022_S2.8h.B,,
MV2014_Ratio M/H normalized B3___1 (30 min),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,
RM2024_Intensity D6-1___2,,
NJH2025_Sub7_MICT_Mid,,
LY2019_P1+,0.47333168564249023,
AS2011_Ratio H/L Proteins Inhi_2,,
BS2014_Log2(Ratio H/L normalized),0.5869544090970494,
UK2020_HCM_2,,
FSO2013_Ratio H/L normalized Rep2___2,,
EP2017_Pervanadate R#3 normalized log2 ratio,0.5656667118329457,0.4504726134843106
RM2024_Intensity D4-3___3,,
RB2022_5_PreStrength,,
NJH2024_Sub4_MICT_Mid,,
TM2022_S2.4h.A,,
RB2022_5_PostStrength,,
GF2025_P6_Sph,,
RB2022_2_PreSprint,,
ZX2022_CB treated Replicate 3,0.6261609678445924,
RM2024_Intensity D6-2___3,,
WZ2023_Pe_025_10min,0.7840880113061027,
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,
AST2020_anti-CD3+PDL2.1,0.6182930164702305,
KBE2022_Log2_Ex_34_U,0.6772482283324278,
WZ2023_Pu_005_10min,0.7693811195545818,
AS2011_Ratio H/L RNAi_2_1,,
NJH2024_Sub9_HIIT_Mid,,
CK2022_9 40-1,0.6451940954179409,
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,
LG2023_GSK3α-1_intensity,,
WZ2023_Pu_025_30min,0.7779866951333224,
AH2018_SILAC_MR_2_X,0.7264143285846049,
HS2024_4_PD_T2,,
NJH2024_Sub4_HIIT_Pre,,
RB2022_2_RecoverySprint,,
AS2011_Ratio H/L Protein RNAi_1,,
RM2024_Intensity D2-1___2,,
CR2017_Ratio Replicate 1.4,0.6212868986740169,
FR2021_Norm.Intensity.B,,
RM2024_Intensity D6-2___1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,
RB2022_5_PostSprint,,
EJN2021_3_Rest_Basal,0.5397874092489691,
CR2017_Ratio Replicate 1.3,0.5918503460387793,
AS2011_Ratio H/L Normalized by Protein RNAi_2,,
KTGR2014_Ratio-Rapa 7 mins,,
AMK2021_120R_p1,,
AH2018_SILAC_3_X,0.6872903972799008,
JJ2018_Ratio M/L normalized pP3,,
AH2018_SILAC_M_2_N,0.6846030329616529,
HS2024_7_PD_T2,,
FSO2013_Ratio H/L normalized Rep1___1,,
AH2018_LFQ_1_C,0.7359770958890243,
AS2011_Ratio H/L Normalized Inhi_1_3,,
KBE2022_Log2_Ex_28_T,0.6853852219535894,
HS2024_3_B_N1,,
RM2024_Intensity D4-2___3,,
WZ2023_Pe_025_30min,0.7790270134924714,
CK2022_11 40-1,0.6425901062941526,
CW2012_10 µM Erl/control Experiment 3 Replicate B,,
AH2018_SILAC_2_X,0.6872986222524173,
MV2014_Ratio H/M normalized A2___2 (2 min),,
AS2011_Ratio H/L RNAi_1_2,,
KS2014_Intensity E15_1,0.6813187709195527,
FSO2013_Ratio H/L normalized Rep2,,
WZ2023_Pu_005_20min,0.7758059037583127,
NJH2024_Sub10_MICT_Post,,
RM2024_Intensity D2-3___1,,
CR2017_Ratio Replicate 1.5,0.6128235132829826,
CW2012_10 µM Gef/control Experiment 2 Replicate B,,
HS2024_7_B_T3,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,0.5749635989832081,
AS2011_Ratio H/L RNAi_1,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,
AH2018_LFQ_M_1_C,0.7354758059032124,
NJH2025_Sub7_MICT_Pre,,
SR2019_SKBR3_Biol_repl_2,,
HS2024_9_B_T2,,
KTGR2014_Ratio-AA 7 mins,,
MV2014_Ratio L/H normalized B3___3 (5 min),,
HS2024_3_PD_T1,,
FSO2013_Ratio M/L normalized Rep3___2,,
SR2019_BT549_Biol_repl_3,,
RCJD2014_20min_mean,0.5856962368363045,
FR2021_Norm.Intensity.H,,
RB2022_2_PreStrength,,
DB2022_LFQ intensity L1.2,,
HS2024_4_B_N1,,
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,
CK2022_1 16-1,0.5884608682850697,
CK2022_1 200-1,0.6130324198165655,
PG2020_Intensity Mock_10h_D,0.5547763626221073,
SR2019_MCF10A_Biol_repl_2,,
JJ2018_Ratio M/L normalized pP2___2,,
HS2024_6_PD_T1,,
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,
RB2022_6_RecoveryEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,
EP2017_Mitotic R#2 normalized log2 ratio,0.5495805878979939,0.40991116586624715
RCJD2014_5min_1,0.650941169056894,
RM2024_Intensity D4-1___1,,
DL2023_24h-1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,
TM2022_S2.4h.C,,
SAS2015_PLX/AZD_Exp2,,
CR2017_Ratio Replicate 3.3,0.5904623995759811,
PG2020_Intensity 2h_C,0.5588025115335727,
VOI2024_Veh2 di,,
ZX2022_CB treated Replicate 2,0.6263937483323044,
KBE2022_Log2_Ex_8_T,0.6621581366417575,
NJH2025_Sub10_MICT_Post,,
HS2024_6_I_T3,,
RN2012_L11,0.566020191766725,
AS2011_Ratio H/L Normalized Inhi_2_2,,
IMM2018_normalised rep. int. Empty-1,,
HS2024_5_PD_T1,,
AH2018_LFQ_M_2_C,0.7023982928955507,
CK2022_3 40-1,0.618998900368232,
RBK2021_1260T Early,,
NJH2024_Sub4_HIIT_Post,,
HS2024_4_I_T1,,
YA2020_Reporter_intensity_Cancer_No.5,0.6690510380048119,
HH2022_Reporter intensity 8,0.6549440648430412,
ZQ2022_N2,0.6353489230272272,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,
FSO2013_Ratio H/L normalized Rep3___3,,
AH2018_TMTMS3_2_N,0.6876563509760308,
EJN2021_5_Rest_Basal,0.540943693795294,
NJH2025_Sub2_HIIT_Post,,
NJH2025_Sub1_MICT_Post,,
HS2024_9_B_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,
JAW2011_Ratio H/L LS2_1,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,
NJH2024_Sub6_HIIT_Pre,,
AH2018_SILAC_3_N,0.6827380664368498,
YA2020_Reporter_intensity_Normal_No.1,0.6825963720987049,
HS2024_3_B_T1,,
JJ2018_Ratio H/L normalized___2,,
RM2024_Intensity D0-2,,
MV2014_Ratio M/L normalized B1___2 (5 min),,
RB2022_7_PostStrength,,
RB2022_1_PostEndurance,,
CR2017_Ratio Replicate 3,0.6320749399193076,
SR2019_Hs578T_Biol_repl_3,0.5631256239403907,
MV2014_Ratio L/H normalized B3___1 (5 min),,
RBK2021_1244T Early,,
RB2022_3_PostSprint,,
NJH2024_Sub13_MICT_Mid,,
KTGR2014_Ratio-AA 2 mins,,
GF2025_P7_Sph,,
HS2024_8_I_T3,,
CF2017_EOC 3,0.616262732727744,
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,0.5588234439305101,
HS2024_6_PD_T3,,
DL2023_12h-2,,
RM2024_Intensity D6-3___1,,
FS2019_Ctr1,,
WZ2023_Pu_010_20min,0.7767123618241141,
AS2011_Ratio H/L_3,,
CK2022_1 40-1,0.6227612389431015,
RNJ2017_Log2_ratio_Tsup:Trest_D1,,
CK2022_8 16-1,0.5901606336657345,
KS2014_Intensity N3,0.6319295777769762,
RB2022_4_RecoveryEndurance,,
RB2022_5_RecoveryEndurance,,
JAW2011_Ratio H/L LS1a_2,,
NJH2024_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_N,0.7070235635398103,
FSO2013_Ratio H/M normalized Rep2,,
RAM2015_Log2 A,0.5802059728713926,
HS2024_8_PD_T1,,
JJ2018_Ratio H/L normalized pP2,,
CF2017_OSE 27,0.6479112554144951,
KS2014_Intensity E15_2,0.6798359734665637,
BS2014_Log2(Ratio H/L protein),,
PG2020_Intensity 8h_A,,
HS2024_7_I_T1,,
VOI2024_Veh3 di,,
RKK2015_TNF-α+SC-514/basal,,
SR2019_JIMT1_Biol_repl_1,,
HW2015_Ratio H/L normalized Exp2,,
HS2024_3_I_N1,,
AH2018_SILAC_M_3_X,0.6883488059640236,
NJH2024_Sub9_HIIT_Post,,
AS2011_Ratio H/L RNAi_1_3,,
GRW2016_Ratio H/L normalized SILAC 1___2,,
NJH2025_Sub1_HIIT_Pre,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,
NJH2024_Sub4_HIIT_Mid,,
VOI2024_0.1uM 2 h_1 di,,
KBE2022_Log2_Ex_6_T,0.6580376065612872,
RM2024_Intensity D4-3___1,,
AH2018_LFQ_4_X,0.7064974720246026,
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
RB2022_8_PostEndurance,,
NJH2025_Sub4_MICT_Mid,,
YP2020_Intensity C30_R1_mult_log2,,
AST2020_anti-CD3.1,0.6174516585906552,
NJH2025_Sub4_HIIT_Post,,
EP2017_Untreated R#4 log2 ratio,0.5698096318814971,0.4768831543849137
HS2024_6_B_N1,,
KBE2022_Log2_Ex_27_T,0.6621681537463622,
CW2012_10 µM Gef/control Experiment 1 Replicate A,,
VOI2024_0.1uM 24 h_1 mono,,
AMK2021_120R_p5,,
AS2011_Ratio H/L Proteins,,
NJH2024_Sub7_HIIT_Post,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),,0.438086803827394
AS2011_Ratio H/L RNAi_2_2,,
RB2022_7_RecoveryStrength,,
AH2018_SILAC_IT_3_X,0.68959040260335,
JAW2011_Ratio H/L,,
PG2020_Intensity 10h_C,,
FSO2013_Ratio M/L normalized Rep2,,
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,
HH2022_Reporter intensity 5,0.6432447438145799,
SR2019_HCC1954_Biol_repl_2,,
CK2022_14 40-1,0.6342868543820319,
RB2022_6_PreSprint,,
NJH2025_Sub12_MICT_Mid,,
PG2020_Intensity 4h_D,0.57618550067284,
NJH2025_Sub2_MICT_Post,,
AH2018_LFQ_4_C,0.708766276711423,
DL2023_control-1,,
AR2021_ALG 10 μM,0.6685076678735321,
JAW2011_Ratio H/L LS2_2,,
AH2018_SILAC_IT_3_N,0.688193846275395,
EJN2021_4_Rest_Ins,0.5539122580238521,
RN2012_H05,0.6045564170350337,
NJH2024_Sub7_HIIT_Mid,,
GF2025_P2_Adh,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,
RB2022_8_PostSprint,,
EJN2021_1_Rest_Ins,0.5539951404277161,
HH2022_Reporter intensity 3,0.6100012871532136,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,
AH2018_SILAC_IT_1_C,0.7106932608360487,
JW2021_After_3,,
GF2025_P8_Sph,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,
JJ2018_Ratio M/L normalized pP2___1,,
AH2018_SILAC_2_N,0.6845476915095277,
CK2022_11 200-1,0.643373708713164,
CK2022_12 200-1,0.6510331529059051,
AS2011_Ratio H/L Normalized by Protein RNAi_1,,
RM2024_Intensity D2-1___3,,
NJH2024_Sub1_MICT_Pre,,
HH2022_Reporter intensity 9,0.6604383597505729,
WZ2023_Su_010_20min,0.7752192978876047,
AH2018_TMTMS2_2_N,0.6870691034934621,
NJH2024_Sub13_MICT_Pre,,
KBE2022_Log2_Ex_41_U,0.6888176272833849,
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),,0.4501536358550433
AH2018_TMTMS3_Pool,0.6896959855590233,
KS2014_Intensity N4,0.6384662325773937,
NJH2024_Sub1_HIIT_Post,,
MM2018_Ratio H/L replicate2,0.6251525070567058,
RM2024_Intensity D4-2___2,,
NJH2024_Sub13_HIIT_Pre,,
CF2017_OSE 26,0.6273326827375975,
CK2022_14 200-1,0.6282165078563282,
SR2019_Hs578T_Biol_repl_1,,
RB2022_7_PostSprint,,
TM2022_mock.4h.A,,
NJH2025_Sub12_HIIT_Pre,,
AH2018_TMTMS3_1_N,0.6988023776758294,
AST2020_anti-CD3+PDL2.2,0.6210709521400563,
PG2020_Intensity Mock_10h_A,0.49144630121700256,
JW2021_After_2,,
NJH2024_Sub2_MICT_Post,,
EJN2021_2_Rest_Ins,0.5457211661054285,
SR2019_LM2_Biol_repl_4,,
CP2009_Ratio H/M,,
JAW2011_Ratio H/L HS,,
CK2022_13 16-1,0.6010128178029605,
GF2025_P1_Adh,,
GF2025_P1_Sph,,
EJN2021_5_Ex_Basal,0.506850697104983,
HS2024_7_I_T3,,
JJ2018_Ratio H/L normalized pP2___2,,
WZ2023_Pe_010_10min,0.7622196013908168,
CF2017_EOC 1,0.5837906448324207,
CK2022_3 200-1,0.612860570913421,
AH2018_LFQ_IT_3_C,0.6872486723036105,
SR2019_Hs578T_Biol_repl_2,,
NJH2024_Sub12_HIIT_Post,,
JJ2018_Ratio H/L normalized pP1___2,,
MV2014_Ratio H/L normalized A1___2 (10 min),,
NJH2024_Sub10_MICT_Mid,,
NJH2024_Sub13_MICT_Post,,
BS2014_Log2(Ratio H/L normalized Rep_1),0.5882980050165872,
RB2022_3_RecoverySprint,,
NJH2025_Sub1_HIIT_Mid,,
RCJD2014_20min_2,0.6261564580497369,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,
HS2024_6_PD_T2,,
HS2024_5_B_T1,,
CW2012_10 µM Gef/control Experiment 2 Replicate A,,
DL2023_12h-3,0.6048295747540436,
SR2019_MDAMB231_Biol_repl_2,,
HS2024_3_B_T2,,
RB2022_6_PreStrength,,
CK2022_2 40-1,0.6133747968168802,
RB2022_1_PostSprint,,
CK2022_4 200-1,0.6122355687415482,
JW2021_Before_2,,
TM2022_S2.12h.A,,
MV2014_Ratio L/M normalized B2___2 (30 min),,
CK2022_5 16-1,0.5973164544726077,
AR2021_ALG 1 μM,0.6411437379389809,
HS2024_4_B_T1,,
MV2014_Ratio M/H normalized A3___1 (10 min),,
SR2019_BT549_Biol_repl_4,,
EJN2021_1_Rest_Basal,0.546387756963768,
NJH2025_Sub8_MICT_Post,,
RCJD2014_5min_3,0.5403583062937735,
CR2017_Ratio Replicate 3.2,0.5643752153579479,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,
GF2025_P7_Adh,,
CK2022_9 16-1,0.6181182987826306,
NJH2024_Sub6_HIIT_Post,,
AMK2021_30R_p3,,
AS2011_Ratio H/L Normalized RNAi_2,,
RM2024_Intensity D0-2___2,,
KS2014_Intensity pY_N4,0.5221962611445203,
CK2022_13 200-1,0.6288096038054684,
AS2011_Ratio H/L Normalized_2,,
PG2020_Intensity 6h_D,0.5353187085212016,
CK2022_16 16-1,0.602576264786235,
FS2019_db/db3,,
CK2022_15 40-1,0.6337752486445307,
NJH2024_Sub9_MICT_Pre,,
BS2014_Log2(Ratio H/L unmodified peptide),,
WZ2023_Su_005_10min,0.756924891901328,
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,
KBE2022_Log2_Ex_41_T,0.6970796920157342,
AMK2021_Ctrl_p1,,
AH2018_LFQ_IT_3_X,0.687257482888567,
HS2024_5_PD_T3,,
AH2018_TMTMS3_3_X,0.6952690425785657,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,
KBE2022_Log2_Ex_40_U,0.6736740781296372,
AH2018_LFQ_M_1_N,0.7039318167217182,
KBE2022_Log2_Ex_27_U,0.6552489901784319,
HW2015_Ratio M/L normalized Exp3,,
RKK2015_TNF-α/IKKb(K44M),,
AH2018_SILAC_M_1_N,0.7061040782507374,
HW2015_Ratio M/L normalized Exp1,,
RB2022_5_RecoveryStrength,,
YP2020_Intensity P10_R1_mult_log2,,
RB2022_7_PreStrength,,
YA2020_Reporter_intensity_Normal_No.4,0.6832653261066803,
NJH2025_Sub13_HIIT_Pre,,
PG2020_Intensity CT_D,0.5753370388445053,
NJH2025_Sub9_MICT_Post,,
VOI2024_Veh1 mono,,
CK2022_12 16-1,0.6143800420398148,
RN2012_L13,0.6058642496449519,
LG2023_Control-1_intensity,,
RM2024_Intensity D6-3___2,,
KBE2022_Log2_Ex_8_U,0.6693926334385806,
SR2019_SKBR3_Biol_repl_3,0.5636495976864552,
NJH2024_Sub1_MICT_Post,,
HS2024_3_I_T2,,
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,
RM2024_Intensity D0-3___3,,
HS2024_6_I_T2,,
CW2012_10 µM Erl/control Experiment 2 Replicate B,,
AS2011_Ratio H/L Protein Inhi_1,,
FSO2013_Ratio H/M normalized Rep2___1,,
GRW2016_Ratio M/L normalized SILAC 5a___2,,
CK2022_10 40-1,0.6397068806616119,
NJH2024_Sub12_HIIT_Pre,,
NJH2024_Sub8_MICT_Pre,,
RM2024_Intensity D0-1___1,,
LY2019_P3+,0.6372094541494719,
HH2022_Reporter intensity 6,0.6690834108286515,
RB2022_2_RecoveryStrength,,
KTGR2014_Ratio-AA 15 mins,,
AS2011_Ratio H/L Normalized RNAi_2_2,,
KS2014_Intensity pY_N3,,
MV2014_Ratio H/L normalized B1___2 (30 min),,
LY2019_P5-,0.6457906121429237,
HW2015_Ratio M/L normalized Exp2,,
SR2019_HCC1419_Biol_repl_1,0.6064467052774242,
AH2018_TMTMS2_3_X,0.7040674752833983,
GF2025_P3_Adh,,
SR2019_JIMT1_Biol_repl_2,,
AH2018_TMTMS2_1_C,0.695956984432966,
RM2024_Intensity D0-1___2,,
LY2019_P4+,0.5499828172910513,
KBE2022_Log2_Ex_19_U,0.6726101150545225,
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,0.6309184563438563,
RB2022_4_PostStrength,,
LG2023_GSK3α-3_intensity,,
YA2020_Reporter_intensity_Cancer_No.1,0.6929399754315284,
AST2020_Control,0.6211871938236315,
JAW2011_Ratio H/L LS1a,,
RCJD2014_5min_mean,0.5787839992952616,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,
NJH2025_Sub1_MICT_Mid,,
TM2022_S2.12h.C,,
NJH2025_Sub9_MICT_Mid,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,
AS2011_Ratio H/L Normalized Inhi_1_2,,
FSO2013_Ratio M/L normalized Rep2___1,,
LG2023_Control-2_intensity,,
NJH2024_Sub8_HIIT_Pre,,
KS2014_Intensity pY_N2,,
RB2022_5_RecoverySprint,,
RB2022_7_RecoverySprint,,
YA2020_Reporter_intensity_Normal_No.3,0.684474507005905,
HS2024_8_B_T2,,
AH2018_LFQ_1_X,0.7361572563095345,
RM2024_Intensity D6-1___1,,
RCJD2014_10min_2,0.6261936198399719,
FR2021_Norm.Intensity.M,,
RM2024_Intensity D0-3___1,,
KS2014_Intensity N2,0.616725306787533,
HH2022_Reporter intensity 1,0.6076807359243986,
HH2022_Reporter intensity 2,0.6101600211035269,
RM2024_Intensity D6-2___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,
RM2024_Intensity D2-3___2,,
YA2020_Reporter_intensity_Normal_No.5,0.6840019014047126,
SR2019_MCF7_Biol_repl_1,0.6247932858123978,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,
HS2024_8_B_T1,,
NJH2025_Sub6_HIIT_Pre,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,
EP2017_Untreated R#2 log2 ratio,0.5953835162886726,0.5170828528098125
SR2019_LM2_Biol_repl_3,,
RB2022_4_RecoveryStrength,,
CR2017_Ratio Replicate 2,0.7003202127901349,
CW2012_10 µM Erl/control Experiment 2 Replicate A,,
FSO2013_Ratio H/M normalized Rep3,,
AR2021_KD 72h,0.6625435620054435,
MV2014_Ratio H/M normalized B2___3 (5 min),,
KBE2022_Log2_Ex_18_U,0.6667781017105581,
AS2011_Ratio H/L Inhi_1_1,,
NJH2024_Sub8_MICT_Post,,
AH2018_TMTMS3_3_C,0.6764872461768059,
KBE2022_Log2_Ex_9_U,0.6727488996224715,
AH2018_SILAC_M_3_N,0.6838790980018973,
KBE2022_Log2_Ex_13_T,0.6607480277235455,
RM2024_Intensity D0-3,,
SR2019_SKBR3_Biol_repl_1,,
PG2020_Intensity Mock_10h_C,0.5472546298421106,
CF2017_OSE 29,0.6378993728569102,
YB2013_Ratio_H_L_Normalized_in_experiment_1,,
NJH2025_Sub1_HIIT_Post,,
DL2023_24h-2,0.5878869248174177,
HS2024_7_B_N2,,
PG2020_Intensity 10h_A,,
RN2012_L12,0.5821953020416327,
MV2014_Ratio M/L normalized B1___3 (5 min),,
NJH2024_Sub8_MICT_Mid,,
AH2018_LFQ_IT_4_C,0.6828859378859221,
SAS2015_PLX/AZD_Exp1,,
FR2021_Norm.Intensity.A,,
FSO2013_Ratio H/M normalized Rep1___1,,
JW2015_Intensity cap2,,
BS2014_Log2(Ratio H/L normalized Rep_2),0.572235016598409,
NJH2024_Sub6_MICT_Post,,
CK2022_8 40-1,0.6191496181846378,
RB2022_7_RecoveryEndurance,,
NJH2025_Sub12_HIIT_Post,,
EJN2021_4_Ex_Basal,0.47969355741993364,
TM2022_S2.12h.B,,
RN2012_L15,0.5718061523290949,
KS2014_Intensity pY_PV3,,
TM2022_S2.4h.B,,
PG2020_Intensity 4h_A,0.5597944975943168,
FSO2013_Ratio H/M normalized Rep2___2,,
TM2022_mock.4h.B,,
KBE2022_Log2_Ex_24_U,0.667555521606754,
NJH2025_Sub13_MICT_Mid,,
KS2014_Intensity C3,0.6896925897586935,
RB2022_1_PreSprint,,
HS2024_4_I_N1,,
CK2022_7 200-1,0.6033467545169974,
CK2022_5 200-1,0.6054764935093279,
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,0.5968405960839651,
FSO2013_Ratio H/L normalized Rep2___1,,
NJH2024_Sub10_HIIT_Mid,,
RB2022_2_PostEndurance,,
AH2018_LFQ_2_C,0.6985720755668127,
AH2018_SILAC_MR_1_X,0.7352934962931202,
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,
IMM2018_normalised rep. int. Empty-2,,
RM2024_Intensity D4-1,,
KBE2022_Log2_Ex_25_U,0.6904456890759428,
AH2018_SILAC_3_C,0.6832622014069246,
EJN2021_5_Rest_Ins,0.5502883090346267,
VOI2024_0.1uM 24 h_3 di,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,
DB2022_LFQ intensity L2.1,,
FSO2013_Ratio H/M normalized Rep1,,
CK2022_4 16-1,0.586516652509544,
AS2011_Ratio H/L,,
SR2019_MCF7_Biol_repl_4,0.6284352471695424,
EJN2021_2_Ex_Ins,0.5321682007313627,
AS2011_Ratio H/L Inhi_2_3,,
JAW2011_Ratio H/L LS1a_1,,
AH2018_LFQ_1_N,0.7019675389163735,
SAS2015_PLX/DMSO_Exp1,,
SFR2015_HL_log2_ratio_avg_c,,
JJ2018_Ratio M/L normalized pP2,,
NJH2024_Sub7_MICT_Mid,,
PG2020_Intensity 6h_B,,
FSO2013_Ratio H/L normalized Rep3,,
GRW2016_Ratio H/L normalized SILAC 2___2,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,
JJ2018_Ratio M/L normalized,,
KTGR2014_Ratio-AA 30 mins,,
JW2021_After_1,,
NJH2025_Sub2_MICT_Mid,,
HS2024_6_B_N2,,
KBE2022_Log2_Ex_9_T,0.6881092310294754,
AH2018_SILAC_IT_2_N,0.6929435696799812,
AH2018_SILAC_IT_1_X,0.6920149977978927,
HW2015_Ratio H/L normalized Exp3,,
HS2024_7_PD_T1,,
UK2020_UA_2,,
RM2024_Intensity D2-1___1,,
GF2025_P10_Sph,,
WZ2023_Pe_025_20min,0.783210396617087,
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,
AH2018_LFQ_2_N,0.7105844812322301,
HS2024_4_I_N2,,
AH2018_TMTMS2_3_N,0.7022795016372356,
RN2012_H06,0.587364396787105,
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
HS2024_4_PD_T3,,
WZ2023_Su_005_30min,0.7743138779737576,
SR2019_HCC1419_Biol_repl_4,,
JJ2018_Ratio H/M normalized___2,,
SR2019_JIMT1_Biol_repl_3,,
AS2011_Ratio H/L Protein,,
UK2020_HCM_3,,
NJH2024_Sub10_HIIT_Post,,
CR2017_Ratio Replicate 3.1,0.6980924878501877,
WZ2023_Su_025_10min,0.7769798573250153,
AH2018_LFQ_IT_4_X,0.6868664706119426,
CP2009_Ratio H/L,,
VOI2024_0.1uM 24 h_3 mono,,
RB2022_4_RecoverySprint,,
RM2024_Intensity D6-3,,
WZ2023_Su_005_20min,0.7702625386731845,
CW2012_10 µM Gef/control Experiment 1 Replicate B,,
SFR2015_HL_log2_ratio_avg_a,,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,
RB2022_1_PreEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,
LG2023_GSK3α-2_intensity,,
EP2017_Pervanadate R#1 log2 ratio,0.5565015438347506,0.39900049498218326
NJH2025_Sub6_HIIT_Post,,
RB2022_6_RecoverySprint,,
KS2014_Intensity,0.6996446691674792,
MV2014_Ratio H/M normalized A2___1 (2 min),,
PG2020_Intensity 8h_D,0.4779387327102907,
LY2019_P7+,0.5904484535418534,
EP2017_Untreated R#1 normalized log2 ratio,0.587100032552453,0.5587014714470764
RN2012_L10,0.5706054962061616,
PG2020_Intensity 4h_C,0.5182871570231203,
EP2017_Mitotic R#3 normalized log2 ratio,0.5463780727188083,0.44546628234893443
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,
DB2022_LFQ intensity L1,,
KBE2022_Log2_Ex_24_T,0.6682813374257273,
RB2022_8_PostStrength,,
AH2018_SILAC_IT_2_X,0.6920226034778575,
HS2024_4_B_T3,,
NJH2024_Sub2_HIIT_Post,,
HS2024_8_B_N2,,
NJH2025_Sub8_HIIT_Pre,,
JJ2018_Ratio H/L normalized pP2___1,,
HS2024_8_I_T2,,
KBE2022_Log2_Ex_6_U,0.6416673621616993,
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,0.605751894551059,
CR2017_Ratio Replicate 1.1,0.664563159182393,
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,0.5876653310090886,
MV2014_Ratio M/H normalized B3___2 (30 min),,
CK2022_16 200-1,0.6271867866854759,
VOI2024_0.1uM 2 h_3 di,,
EP2017_Mitotic R#1 normalized log2 ratio,0.5489039998488465,0.4782890583048575
GF2025_P9_Sph,,
CK2022_6 200-1,0.6053034637032861,
NJH2024_Sub7_MICT_Post,,
AH2018_TMTMS3_2_X,0.6656512024248588,
NJH2024_Sub8_HIIT_Post,,
DB2022_LFQ intensity R1,,
JW2015_Intensity cap3,,
SR2019_HCC1954_Biol_repl_1,0.5702818610431648,
HS2024_4_I_T2,,
NJH2024_Sub2_MICT_Mid,,
VOI2024_0.1uM 2 h_2 mono,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,
HS2024_4_PD_T1,,
SAS2015_AZD/DMSO_Exp1,,
NJH2024_Sub1_MICT_Mid,,
IMM2018_normalised rep. int. CDK5L-3,,
HS2024_3_B_T3,,
MV2014_Ratio L/H normalized A3___2 (2 min),,
NJH2025_Sub13_MICT_Pre,,
SR2019_MDAMB231_Biol_repl_3,0.5753824574477167,
GRW2016_Ratio H/L normalized SILAC 4___1,,
MM2018_Ratio H/L replicate1,0.566766155652488,
PG2020_Intensity 2h_D,0.5585174704302858,
EP2017_Untreated R#3 normalized log2 ratio,0.5605542661366972,0.3882386672982045
MV2014_Ratio M/H normalized A3___3 (10 min),,
NJH2024_Sub7_HIIT_Pre,,
JAW2011_Ratio H/L LS2,,
CK2022_8 200-1,0.5999279535791063,
KS2014_Intensity pY_C4,,
CR2017_Ratio Replicate 3.5,0.632689141480275,
RB2022_7_PostEndurance,,
NJH2025_Sub4_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,0.578091566810793,
TM2022_mock.12h.A,,
JJ2018_Ratio H/L normalized pP1,,
EP2017_Pervanadate R#2 normalized log2 ratio,0.5624593812297444,0.39006417503119967
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,
KS2014_Intensity pY_E5_4,0.6160861371029968,
RM2024_Intensity D4-3___2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,
AH2018_SILAC_2_C,0.6874851701504365,
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
HS2024_7_I_N1,,
KBE2022_Log2_Ex_29_T,0.6864103364763383,
HS2024_7_I_T2,,
AS2011_Ratio H/L Normalized RNAi_2_3,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,
HS2024_6_B_T2,,
AMK2021_45I_p5,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,
SAS2015_PLX/DMSO_Exp2,,
EJN2021_1_Ex_Basal,0.5249940514239754,
FR2021_Intensity.M,,
RB2022_2_PostSprint,,
AH2018_SILAC_MR_3_N,0.726168460373811,
MV2014_Ratio H/L normalized B1___3 (30 min),,
CF2017_FTE 13,0.6696877018809305,
PG2020_Intensity CT_C,0.5401928233365195,
ZCP2016_Ratio H/L Rep 1,,
FS2019_db/db2,,
KS2014_Intensity pY_PV4,,
KBE2022_Log2_Ex_39_U,0.6924300633944777,
EP2017_Untreated R#3 log2 ratio,0.5679687591481374,0.3889055453849022
RB2022_2_PostStrength,,
AS2011_Ratio H/L Normalized_1,,
MV2014_Ratio M/H normalized A3___2 (10 min),,
CR2017_Ratio Replicate 3.4,0.5702127785630428,
HS2024_8_PD_T2,,
FS2019_Ctr2,,
RB2022_6_PreEndurance,,
FR2021_Norm.Intensity.G,,
NJH2025_Sub9_HIIT_Post,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,
RM2024_Intensity D4-3,,
HS2024_8_B_N1,,
NJH2025_Sub10_MICT_Mid,,
KBE2022_Log2_Ex_15_U,0.6477517272079393,
AS2011_Ratio H/L Normalized Inhi_2,,
RKK2015_TNF-α/SC-514,,
RB2022_3_PreSprint,,
CR2017_Ratio Replicate 2.3,0.5681995823355102,
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,
GF2025_P4_Adh,,
YA2020_Reporter_intensity_Normal_No.2,0.6872239831078529,
YP2020_Intensity P30_R2_mult_log2,,
NJH2025_Sub13_MICT_Post,,
HS2024_4_B_N2,,
HS2024_3_PD_T3,,
AMK2021_120R_p3,,
MV2014_Ratio L/H normalized A3___3 (2 min),,
NJH2025_Sub10_HIIT_Pre,,
FR2021_Intensity.G,,
RAM2015_Log2 C,0.7004265474726109,
AS2011_Ratio H/L Proteins Inhi_1,,
FSO2013_Ratio H/M normalized Rep1___3,,
AH2018_LFQ_M_2_N,0.7144191989623646,
MV2014_Ratio M/L normalized A1___3 (2 min),,
KBE2022_Log2_Ex_40_T,0.6790838025139476,
CK2022_2 16-1,0.5821211850882813,
RAM2015_Log2 B,0.6733424129122721,
YP2020_Intensity C10_R1_mult_log2,,
FSO2013_Ratio M/L normalized Rep1___2,,
NJH2025_Sub8_MICT_Pre,,
EJN2021_4_Rest_Basal,0.5466305114940799,
YB2013_Ratio_H_L_Normalized_in_experiment_2,,
JJ2018_Ratio H/M normalized pP3___1,,
VOI2024_Veh2 mono,,
HS2024_6_B_T1,,
UK2020_HCM_5,,
NJH2025_Sub10_HIIT_Post,,
VOI2024_0.1uM 2 h_3 mono,,
JW2015_Intensity pre3,,
AS2011_Ratio H/L Normalized Inhi_2_1,,
DL2023_24h-3,,
HS2024_7_PD_T3,,
PG2020_Intensity Mock_10h_B,0.5680536974362319,
WZ2023_Su_025_30min,0.7777462117604186,
AH2018_LFQ_4_N,0.7239168708365598,
CR2017_Ratio Replicate 1.2,0.6076305874993989,
AS2011_Ratio H/L Normalized by Proteins,,
RB2022_6_RecoveryStrength,,
HS2024_8_I_N1,,
AMK2021_Ctrl_p3,,
AS2011_Ratio H/L Protein Inhi_2,,
HH2022_Reporter intensity 7,0.6614582570055595,
AH2018_SILAC_M_1_X,0.7162361230950608,
RB2022_7_PreEndurance,,
VOI2024_0.1uM 24 h_2 di,,
DL2023_control-2,0.5088408795510484,
LY2019_P6+,0.5796159269479754,
DB2022_LFQ intensity R2,,
GF2025_P6_Adh,,
VOI2024_Veh1 di,,
AS2011_Ratio H/L RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,
VOI2024_Veh3 mono,,
HS2024_5_I_T2,,
NJH2025_Sub7_HIIT_Mid,,
MV2014_Ratio H/L normalized B1___1 (30 min),,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,
RB2022_6_PostSprint,,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,
AS2011_Ratio H/L Inhi_1,,
AS2011_Ratio H/L Normalized RNAi_1_2,,
AH2018_TMTMS3_2_C,0.7001319105333735,
SR2019_Hs578T_Biol_repl_4,,
RB2022_8_PreStrength,,
KS2014_Intensity C5,0.6879357055788945,
RM2024_Intensity D0-1,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,
YP2020_Intensity P30_R1_mult_log2,,
NJH2025_Sub2_HIIT_Pre,,
RB2022_3_RecoveryEndurance,,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,
GF2025_P9_Adh,,
RB2022_3_PostStrength,,
TM2022_S2.8h.A,,
AS2011_Ratio H/L RNAi_1_1,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,
NJH2025_Sub2_MICT_Pre,,
MV2014_Ratio L/M normalized A2___3 (10 min),,
MV2014_Ratio H/M normalized A2___3 (2 min),,
HS2024_4_B_T2,,
SR2019_BT549_Biol_repl_1,,
AH2018_LFQ_M_4_N,0.726527972653265,
NJH2024_Sub8_HIIT_Mid,,
PG2020_Intensity 8h_B,0.4867138770980013,
AH2018_LFQ_2_X,0.6820013000760623,
PG2020_Intensity 2h_B,0.5187338405705736,
AS2011_Ratio H/L Proteins RNAi_1,,
RB2022_4_PostSprint,,
KS2014_Intensity E15_3,0.6678577719182998,
GF2025_P3_Sph,,
DB2022_LFQ intensity L2,,
MV2014_Ratio H/L normalized A1___1 (10 min),,
AH2018_SILAC_1_C,0.7083568092957725,
NJH2024_Sub1_HIIT_Pre,,
FSO2013_Ratio M/L normalized Rep2___2,,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),,0.4778219355138084
AS2011_Ratio H/L RNAi_2_3,,
AH2018_SILAC_IT_1_N,0.6887112381253409,
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,
RB2022_4_PreEndurance,,
JJ2018_Ratio M/L normalized pP1,,
CR2017_Ratio Replicate 2.4,0.5861995717559022,
ZQ2022_N1,0.6455672936940773,
LY2019_P6-,0.621694817151927,
RM2024_Intensity D2-3,,
UK2020_HCM_1,,
JW2015_Intensity pre2,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,
RM2024_Intensity D2-1,,
NJH2025_Sub12_MICT_Post,,
MV2014_Ratio H/M normalized B2___2 (5 min),,
RN2012_L14,0.5772944066476623,
AH2018_LFQ_3_N,0.714236133021901,
RKK2015_TNF-α/IKKb,,
SFR2015_HL_log2_ratio_std_b,,
UK2020_UA_1,,
KBE2022_Log2_Ex_13_U,0.6775681755004701,
AS2011_Ratio H/L Normalized Inhi_1,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,
RB2022_1_RecoverySprint,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,0.5802861716951103,
JJ2018_Ratio H/L normalized pP3,,
CK2022_7 40-1,0.6215398592671751,
AS2011_Ratio H/L Inhi_1_3,,
NJH2025_Sub10_HIIT_Mid,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,
JAW2011_Ratio H/L LS1b_1,,
PG2020_Intensity 4h_B,0.542855464317729,
SR2019_BT549_Biol_repl_2,,
RM2024_Intensity D4-2,,
DB2022_LFQ intensity R2.2,,
JJ2018_Ratio H/L normalized,,
RB2022_5_PostEndurance,,
HS2024_5_PD_T2,,
WZ2023_Su_025_20min,0.7753864157066221,
RM2024_Intensity D2-2___1,,
IMM2018_normalised rep. int. CDK5L-2,,
LY2019_P8-,0.550691059556018,
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,
FSO2013_Ratio H/L normalized Rep1,,
NJH2024_Sub2_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,0.5610234073580064,
CK2022_13 40-1,0.634338477994134,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,
RN2012_H02,0.6173198528328625,
PG2020_Intensity 10h_D,,
RB2022_8_PreEndurance,,
HS2024_3_B_N2,,
EJN2021_4_Ex_Ins,0.5419957098395854,
AS2011_Ratio H/L Normalized by Protein,,
EJN2021_1_Ex_Ins,0.5528529801150474,
EP2017_Pervanadate R#3 log2 ratio,0.5653500706040316,0.4504028449947417
FSO2013_Ratio M/L normalized Rep1___3,,
NJH2025_Sub4_HIIT_Mid,,
RCJD2014_5min_2,0.5583070839107132,
RB2022_6_PostStrength,,
AH2018_SILAC_MR_3_C,0.704041257830653,
AH2018_LFQ_M_4_C,0.7139746249852074,
NJH2024_Sub4_MICT_Pre,,
AS2011_Ratio H/L Normalized Inhi_1_1,,
DL2023_12h-1,,
MV2014_Ratio L/M normalized B2___1 (30 min),,
DB2022_LFQ intensity L1.1,,
NJH2025_Sub6_MICT_Pre,,
NJH2025_Sub6_MICT_Post,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,0.5869719438551123,
RN2012_H04,0.5776132631218996,
CK2022_6 40-1,0.6137198321430125,
DB2022_LFQ intensity R2.1,,
KBE2022_Log2_Ex_42_U,0.6637841589439318,
LY2019_P3-,0.5944811551141919,
FR2021_Intensity.A,,
EJN2021_3_Ex_Ins,0.548040807048006,
MV2014_Ratio M/L normalized A1___1 (2 min),,
WZ2023_Pe_005_30min,0.758578540853703,
HS2024_8_PD_T3,,
EJN2021_3_Ex_Basal,0.48193654940399605,
AST2020_Control.1,0.6178441175820475,
JW2015_Intensity cap1,,
PG2020_Intensity CT_A,0.5472551530357851,
FS2019_Ctr3,,
WZ2023_Pu_025_20min,0.7754629404638201,
NJH2025_Sub4_MICT_Post,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,
GF2025_P10_Adh,,
RB2022_1_RecoveryStrength,,
SR2019_HCC1954_Biol_repl_4,,
FR2021_Norm.Intensity.N,,
HS2024_5_B_N1,,
FSO2013_Ratio H/M normalized Rep3___3,,
AH2018_TMTMS2_2_C,0.6890085344767723,
RB2022_4_PreSprint,,
DB2022_Intensity R2,,
AH2018_TMTMS2_Pool,0.6987786898671992,
HS2024_8_I_N2,,
RB2022_3_RecoveryStrength,,
NJH2024_Sub6_HIIT_Mid,,
AH2018_SILAC_M_1_C,0.709639938154138,
LY2019_P8+,0.5448408626559557,
RB2022_2_RecoveryEndurance,,
JJ2018_Ratio H/M normalized pP2___1,,
JAW2011_Ratio H/L HS_1,,
RB2022_3_PostEndurance,,
KS2014_Intensity pY_PV1,,
JAW2011_Ratio H/L LS1b_2,,
SR2019_MCF7_Biol_repl_2,0.6242596365985283,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),,0.4410920349705765
AS2011_Ratio H/L Normalized RNAi_1_1,,
AH2018_LFQ_M_4_X,0.7122049649184419,
NJH2024_Sub6_MICT_Pre,,
JJ2018_Ratio M/L normalized pP1___2,,
YP2020_Intensity C30_R2_mult_log2,,
NJH2024_Sub9_HIIT_Pre,,
AS2011_Ratio H/L Normalized Inhi_2_3,,
RM2024_Intensity D0-1___3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,
KBE2022_Log2_Ex_28_U,0.6765796089556945,
GRW2016_Ratio H/L normalized SILAC 1___1,,
CF2017_FTE 17,0.6596605296587446,
LY2019_P2-,0.6263765675130362,
AH2018_LFQ_IT_1_X,0.7165136345873796,
JJ2018_Ratio H/L normalized pP3___1,,
RB2022_8_RecoveryStrength,,
WZ2023_Pe_005_20min,0.759500272718518,
AST2020_Control.2,0.6160357101139123,
NJH2025_Sub6_MICT_Mid,,
RCJD2014_10min_1,0.5927781162469977,
FSO2013_Ratio H/L normalized Rep2___3,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,
HS2024_3_I_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,
CK2022_4 40-1,0.6136286449159134,
SR2019_MCF10A_Biol_repl_4,0.5708239042737921,
KS2014_Intensity pY_C5,0.59579940750193,
NJH2025_Sub4_MICT_Pre,,
NJH2024_Sub9_MICT_Post,,
CF2017_OSE 28,0.6325969162792213,
HS2024_5_B_T2,,
HS2024_6_I_T1,,
HS2024_5_B_T3,,
JJ2018_Ratio H/M normalized pP1___1,,
KBE2022_Log2_Ex_36_U,0.6859661583445392,
AH2018_TMTMS3_3_N,0.6919527092931844,
SR2019_HCC1419_Biol_repl_2,0.5854001752757977,
FR2021_Intensity.N,,
AS2011_Ratio H/L Inhi_2_1,,
AH2018_SILAC_MR_1_C,0.737377780175365,
NJH2024_Sub1_HIIT_Mid,,
NJH2025_Sub8_HIIT_Mid,,
EP2017_Mitotic R#3 log2 ratio,0.5538363150940232,0.4500421900658644
KBE2022_Log2_Ex_36_T,0.6985704267467052,
NJH2025_Sub6_HIIT_Mid,,
WZ2023_Pu_005_30min,0.7615148650415445,
KS2014_Intensity C2,0.6890665720537895,
FSO2013_Ratio H/L normalized Rep1___2,,
RM2024_Intensity D2-2,,
KBE2022_Log2_Ex_42_T,0.6817442188502382,
CK2022_9 200-1,0.641827439073645,
GRW2016_Ratio H/L normalized SILAC 2___1,,
JJ2018_Ratio H/M normalized pP3___2,,
DB2022_LFQ intensity R1.1,,
CK2022_10 200-1,0.6398685980651186,
NJH2024_Sub9_MICT_Mid,,
JAW2011_Ratio H/L_2,,
HS2024_7_I_N2,,
RBK2021_1332T Late,,
LY2019_P1-,0.6030608224353071,
RKK2015_TNF-α/basal.1,,
RKK2015_TNF-α/TNF-α+SC-514,,
CR2017_Ratio Replicate 2.5,0.5909181442769637,
HS2024_3_I_T3,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,
AS2011_Ratio H/L Normalized RNAi_1,,
KS2014_Intensity E15_4,0.6883461571628522,
ZQ2022_C3,0.567135032345173,
EJN2021_3_Rest_Ins,0.5536231770406168,
YP2020_Intensity P10_R2_mult_log2,,
MV2014_Ratio H/L normalized A1___3 (10 min),,
NJH2025_Sub1_MICT_Pre,,
KBE2022_Log2_Ex_39_T,0.7081916807825834,
FSO2013_Ratio H/M normalized Rep3___2,,
RM2024_Intensity D6-2,,
EP2017_Untreated R#1 log2 ratio,0.5945575373218822,0.561639799070694
RKK2015_SC-514/basal,,
RM2024_Intensity D6-1___3,,
WZ2023_Pu_010_10min,0.7595675484435391,
NJH2025_Sub9_HIIT_Mid,,
SR2019_SKBR3_Biol_repl_4,0.5731771219587287,
HS2024_5_I_T3,,
KS2014_Intensity N1,0.6295831242876004,
NJH2024_Sub12_MICT_Post,,
TM2022_S2.8h.C,,
CR2017_Ratio Replicate 1,0.639072721185907,
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,0.5791425663994803,
JJ2018_Ratio H/M normalized pP3,,
AH2018_SILAC_MR_2_C,0.7365817926402203,
LATM2013_Log2 Ratio (Medium/Light) Forward,0.5607377517610938,
PG2020_Intensity 2h_A,0.4558361922495011,
NJH2024_Sub6_MICT_Mid,,
NJH2025_Sub13_HIIT_Post,,
AH2018_SILAC_MR_3_X,0.7174581108343933,
JJ2018_Ratio H/M normalized___1,,
RCJD2014_15min_2,0.5930277738407513,
AS2011_Ratio H/L_2,,
AS2011_Ratio H/L Normalized,,
RN2012_H03,0.6011503687969803,
HS2024_5_B_N2,,
HS2024_5_I_N1,,
HS2024_6_I_N1,,
AR2021_KD 48h,0.6417147339693607,
FR2021_Intensity.B,,
RB2022_3_PreEndurance,,
HS2024_5_I_T1,,
NJH2024_Sub10_MICT_Pre,,
SR2019_LM2_Biol_repl_2,,
AST2020_anti-CD3,0.6198334189138767,
SR2019_MDAMB231_Biol_repl_1,,
RM2024_Intensity D2-3___3,,
WZ2023_Pe_005_10min,0.7608339093338077,
KBE2022_Log2_Ex_29_U,0.6689998439823729,
HS2024_7_B_T1,,
AH2018_LFQ_M_2_X,0.6881412877487755,
AH2018_LFQ_IT_4_N,0.6823624534677503,
CK2022_15 200-1,0.6258537000432806,
RM2024_Intensity D4-1___2,,
JJ2018_Ratio H/M normalized,,
JJ2018_Ratio M/L normalized pP3___1,,
KBE2022_Log2_Ex_34_T,0.6835460850169778,
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,0.5985764549183988,
LY2019_P2+,0.5544215806648403,
LATM2013_Log2 Ratio (Light/Medium) Reverse,0.6060988445237556,
CK2022_2 200-1,0.610969750147714,
AS2011_Ratio H/L Protein RNAi_2,,
MV2014_Ratio L/H normalized A3___1 (2 min),,
WZ2023_Su_010_30min,0.7598263734519595,
RN2012_H01,0.5994257139754585,
KTGR2014_Ratio-Rapa 2 mins,,
EJN2021_2_Rest_Basal,0.550981308990819,
KS2014_Intensity pY_E5_3,0.60104093979082,
MM2018_Ratio H/L replicate 3,0.5845889841961447,
EP2017_Pervanadate R#1 normalized log2 ratio,0.5568085896002187,0.39908756560812897
HS2024_8_B_T3,,
YA2020_Reporter_intensity_Cancer_No.3,0.6762101505705228,
KBE2022_Log2_Ex_44_U,0.6622972415765344,
WZ2023_Pe_010_20min,0.7750708491219589,
KS2014_Intensity pY_C6,0.6060901022266485,
AS2011_Ratio H/L Normalized_3,,
RCJD2014_15min_mean,0.6547196959733804,
RB2022_3_PreStrength,,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,
RCJD2014_10min_mean,0.4683953438120357,
KS2014_Intensity C1,0.6960592158389686,
FSO2013_Ratio H/M normalized Rep3___1,,
AH2018_SILAC_M_3_C,0.684054480138559,
RKK2015_TNF-α+IKKb/TNF-α,,
RM2024_Intensity D0-3___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,
AH2018_SILAC_M_2_C,0.6875738675140793,
AH2018_SILAC_M_2_X,0.6858318824956298,
KTGR2014_Ratio-Rapa 15 mins,,
RM2024_Intensity D4-2___1,,
KBE2022_Log2_Ex_15_T,0.6692242798483171,
VOI2024_0.1uM 24 h_1 di,,
WZ2023_Su_010_10min,0.759974419366006,
PG2020_Intensity 6h_C,0.5285962468113704,
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,
JJ2018_Ratio M/L normalized pP1___1,,
AH2018_LFQ_M_3_N,0.719110264065779,
VOI2024_0.1uM 24 h_2 mono,,
AH2018_TMTMS2_3_C,0.7042283455048977,
CK2022_15 16-1,0.6000007840582101,
CK2022_3 16-1,0.5966034873162953,
LY2019_P4-,0.5896873834665561,
FSO2013_Ratio H/L normalized Rep3___2,,
KS2014_Intensity pY_PV2,,
HS2024_3_I_N2,,
GF2025_P8_Adh,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,
GF2025_P5_Sph,,
CK2022_10 16-1,0.6102634937319503,
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,
VOI2024_0.1uM 2 h_2 di,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),,
NJH2024_Sub2_HIIT_Mid,,
AMK2021_45I_p3,,
NJH2024_Sub13_HIIT_Mid,,
DB2022_LFQ intensity R1.2,,
DB2022_Intensity R1,,
NJH2024_Sub12_MICT_Mid,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,
UK2020_HCM_4,,
SAS2015_AZD/DMSO_Exp2,,
IMM2018_normalised rep. int. CDK5L-1,,
DB2022_LFQ intensity L2.2,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,
EP2017_Mitotic R#1 log2 ratio,0.5542404029777654,0.48058512926643254
EJN2021_2_Ex_Basal,0.5518459659414304,
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,
KTGR2014_Ratio-Rapa 30 mins,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,
CF2017_FTE 16,0.6496381468511108,
AR2021_L41 10 μM,0.7086708290959591,
CF2017_EOC 2,0.611944618044369,
RB2022_6_PostEndurance,,
AH2018_SILAC_1_N,0.7066348660326381,
NJH2024_Sub10_HIIT_Pre,,
AS2011_Ratio H/L Inhi_1_2,,
UK2020_HCM_6,,
RB2022_7_PreSprint,,
NJH2024_Sub2_MICT_Pre,,
HS2024_3_PD_T2,,
CK2022_6 16-1,0.587483125524162,
ZX2022_CB treated Replicate 1,0.6205417748704786,
BS2014_Log2(Ratio H/L normalized Rep_3),0.5801870010474813,
TM2022_mock.12h.C,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,
HH2022_Reporter intensity 0,0.6093667860141411,
RM2024_Intensity D2-2___2,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,
RB2022_1_PreStrength,,
JJ2018_Ratio H/M normalized pP2___2,,
AH2018_TMTMS2_2_X,0.6826778839073945,
AR2021_L41 1 μM,0.7092631435466935,
JJ2018_Ratio H/M normalized pP1___2,,
AH2018_TMTMS2_1_N,0.695899958057157,
NJH2025_Sub10_MICT_Pre,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,
ZX2022_Control Replicate 3,0.6233701748559807,
KS2014_Intensity C4,0.6936747998696049,
AS2011_Ratio H/L Inhi_2,,
KBE2022_Log2_Ex_18_T,0.6813411578931708,
NJH2025_Sub9_MICT_Pre,,
RCJD2014_20min_1,0.5816011456869722,
MV2014_Ratio H/M normalized B2___1 (5 min),,
FSO2013_Ratio M/L normalized Rep2___3,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,
SR2019_MCF10A_Biol_repl_3,,
HS2024_7_B_T2,,
SAS2015_PLX/DMSO_Exp3,,
AMK2021_Ctrl_p5,,
NJH2025_Sub2_HIIT_Mid,,
AH2018_LFQ_M_3_C,0.7339809507107304,
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,
YA2020_Reporter_intensity_Cancer_No.2,0.6769340874983908,
FSO2013_Ratio H/M normalized Rep2___3,,
RB2022_8_PreSprint,,
AH2018_SILAC_IT_3_C,0.7077928347563661,
WZ2023_Pu_025_10min,0.7822947659365681,
RM2024_Intensity D2-2___3,,
AS2011_Ratio H/L_1,,
RCJD2014_10min_3,0.5758275455172425,
FSO2013_Ratio M/L normalized Rep3___1,,
SR2019_JIMT1_Biol_repl_4,,
YP2020_Intensity C10_R2_mult_log2,,
ZCP2016_Ratio H/L Rep 2,,
CF2017_EOC 4,0.601818045246815,
JJ2018_Ratio H/L normalized pP1___1,,
WZ2023_Pe_010_30min,0.7765455839058578,
MV2014_Ratio L/M normalized B2___3 (30 min),,
AH2018_LFQ_IT_3_N,0.6846817041874594,
KS2014_Intensity C6,0.6160889286021597,
ZQ2022_N3,0.6358848304538018,
HW2015_Ratio H/L normalized Exp1,,
CK2022_12 40-1,0.6485993707309978,
NJH2024_Sub7_MICT_Pre,,
ZX2022_Control Replicate 1,0.630308430838761,
JJ2018_Ratio H/M normalized pP1,,
CK2022_16 40-1,0.6389447947385961,
AH2018_SILAC_IT_2_C,0.7169343525428986,
CK2022_5 40-1,0.6199625362407893,
AH2018_LFQ_3_X,0.7244148601570056,
UK2020_UA_3,,
LY2019_P7-,0.592843672663789,
GF2025_P5_Adh,,
RB2022_1_PostStrength,,
JAW2011_Ratio H/L LS1b,,
FSO2013_Ratio H/L normalized Rep3___1,,
SR2019_HCC1954_Biol_repl_3,0.5402807142757937,
CR2017_Ratio Replicate 2.2,0.5856986173598512,
VOI2024_0.1uM 2 h_1 mono,,
MV2014_Ratio L/M normalized A2___1 (10 min),,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,
CK2022_11 16-1,0.6144030736499677,
ZQ2022_C1,0.5576892474285655,
CR2017_Ratio Replicate 2.1,0.6303434412226321,
PG2020_Intensity CT_B,0.4974574446952551,
JJ2018_Ratio M/L normalized___2,,
AH2018_SILAC_MR_1_N,0.7134026028834417,
KS2014_Intensity pY_E5_1,0.6036202779434636,
JW2021_Before_3,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,
MV2014_Ratio M/H normalized B3___3 (30 min),,
FS2019_db/db1,,
NJH2025_Sub9_HIIT_Pre,,
JAW2011_Ratio H/L_1,,
RCJD2014_20min_3,0.5336407118158223,
AH2018_LFQ_3_C,0.7338124565433796,
JJ2018_Ratio M/L normalized pP3___2,,
AMK2021_45I_p1,,
NJH2025_Sub8_HIIT_Post,,
AH2018_LFQ_M_3_X,0.7235759822723681,
YA2020_Reporter_intensity_Cancer_No.4,0.6680933506124213,
KS2014_Intensity pY_E5_2,,
FSO2013_Ratio H/L normalized Rep1___3,,
GF2025_P4_Sph,,
RB2022_2_PreEndurance,,
JW2021_Before_1,,
KBE2022_Log2_Ex_25_T,0.6889408219765697,
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,
MV2014_Ratio L/M normalized A2___2 (10 min),,
JJ2018_Ratio M/L normalized___1,,
FR2021_Intensity.H,,
CK2022_14 16-1,0.6024972169122754,
AST2020_anti-CD3+PDL2,0.6205785057856067,
MV2014_Ratio M/L normalized B1___1 (5 min),,
KBE2022_Log2_Ex_19_T,0.6903095170995388,
KS2014_Intensity pY_N1,0.4741631949206541,
RB2022_1_RecoveryEndurance,,
FSO2013_Ratio H/M normalized Rep1___2,,
HS2024_8_I_T1,,
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,
EP2017_Mitotic R#2 log2 ratio,0.5542868889567416,0.4145417982645805
AH2018_TMTMS2_1_X,0.6973297819616664,
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,
ZCP2016_Ratio H/L Rep 3,,
AS2011_Ratio H/L Normalized RNAi_1_3,,
SR2019_MCF10A_Biol_repl_1,0.5598534189513782,
NJH2025_Sub8_MICT_Mid,,
EJN2021_5_Ex_Ins,0.5329991739528523,
HS2024_6_I_N2,,
HH2022_Reporter intensity 4,,
RBK2021_1326T Late,,
TM2022_mock.12h.B,,
NJH2024_Sub12_MICT_Pre,,
RCJD2014_15min_3,0.5648949217005977,
MV2014_Ratio L/H normalized B3___2 (5 min),,
LG2023_Control-3_intensity,,
JJ2018_Ratio H/L normalized pP3___2,,
CF2017_FTE 15,0.6410167425468344,
HS2024_4_I_T3,,
AH2018_SILAC_1_X,0.7158071532190106,
PG2020_Intensity 10h_B,,
AH2018_TMTMS3_1_X,0.7008567339199671,
CF2017_FTE 14,0.6581924130382089,
NJH2024_Sub13_HIIT_Post,,
RM2024_Intensity D6-3___3,,
NJH2025_Sub7_HIIT_Pre,,
RBK2021_1259T Early,,
RKK2015_IKK+TNF-α/IKKb,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,
PG2020_Intensity 6h_A,0.5762119012137571,
SR2019_HCC1419_Biol_repl_3,0.6026487693400048,
KBE2022_Log2_Ex_14_T,0.6755133081079743,
EP2017_Untreated R#2 normalized log2 ratio,0.5885271745268051,0.5126910102955029
RM2024_Intensity D0-2___1,,
DB2022_Intensity L1,,
LY2019_P5+,0.5635514376204139,
HS2024_5_I_N2,,
SAS2015_PLX/AZD_Exp3,,
EP2017_Pervanadate R#2 log2 ratio,0.5619683648660726,0.38969892847185883
AS2011_Ratio H/L Normalized RNAi_2_1,,
